Pulmonary Hypertension on Prognosis of Acute Myocardial Infarction Patients With Reduced Left Ventricular Function
NCT06186713 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4784
Last updated 2024-01-02
Summary
Pulmonary hypertension (PH) has a negative effect on acute myocardial infarction (AMI) patients and appears to be closely associated with reduced left ventricular function. However, its impact on AMI patients with reduced left ventricular function remains unclear. This retrospective study included AMI patients with reduced left ventricular function to investigate the prognostic value of PH in this specific type of patient. Meanwhile, a nomogram would be established basing on the identified independent risk factors, hoping to provide a novel risk stratification for them.
Conditions
- Acute Myocardial Infarction
- Pulmonary Hypertension
Interventions
- OTHER
-
This was an observational study, and no Intervention was given to the patients.
This was an observational study, and no Intervention was given to the patients.
Sponsors & Collaborators
-
First Affiliated Hospital Xi'an Jiaotong University
lead OTHER
Principal Investigators
-
Yang Yan · First Affiliated Hospital Xi'an Jiaotong University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-30
- Primary Completion
- 2023-07-31
- Completion
- 2023-08-01
Countries
- China
Study Locations
More Related Trials
-
Safety Surveillance of Targeted Drugs for Pulmonary Hypertension Using a Computerized Follow-up System: a Nationwide Cohort Study
NCT05372263 ·Status: RECRUITING
-
Efficacy of Triple-Combination Therapy in Severe PAH-CHD
NCT06196801 ·Status: ACTIVE_NOT_RECRUITING
-
Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease
NCT02742909 ·Status: COMPLETED ·Phase: PHASE4
-
Endothelial Cell Activation and Total Pulmonary Resistance in PAH
NCT06035861 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Airway and Pulmonary Vascular Endothelial Function in Healthy Smokers: Effect of Inhaled Glucocorticosteroid Treatment
NCT02141633 ·Status: COMPLETED ·Phase: NA
-
miRNA and Myokines in Patients With PAH
NCT03905083 ·Status: WITHDRAWN ·Phase: NA
-
Evaluation of the Pulmonary Vascular Reactivity Test in Patients With Pulmonary Arterial Hypertension and a Cardiac Shunt
NCT02138708 ·Status: WITHDRAWN ·Phase: NA
-
A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension
NCT06554301 ·Status: RECRUITING ·Phase: PHASE1
-
Effect of Morphine on Dyspnea and 6-Minute Walk Distance in Pulmonary Arterial Hypertension
NCT03401476 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.
NCT00423202 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
NCT03015402 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension
NCT02080533 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Retrospective Data Analysis of Data From the Zurich PH Registry
NCT03198910 ·Status: COMPLETED
-
Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric Oxide
NCT04231084 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
NCT07333183 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.
NCT00423748 ·Status: COMPLETED ·Phase: PHASE3
-
the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension
NCT02061787 ·Status: RECRUITING
-
Assessing the Utility of Submaximal CPET in Treatment Management of PAH
NCT05977933 ·Status: NOT_YET_RECRUITING
-
Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH
NCT03888365 ·Status: COMPLETED
-
Impact of Rehabilitation Program on PAH Patients Treated With Macitentan.
NCT03045666 ·Status: UNKNOWN ·Phase: NA
-
Acute Response of Iloprost Inhalation Using the Breelib Nebulizer in Pulmonary Arterial Hypertension
NCT03365479 ·Status: COMPLETED ·Phase: NA
-
Trimetazidine in Pulmonary Artery Hypertension
NCT02102672 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Endothelin-1 Receptor Blockade on Circulating Endothelial Microparticles Levels in Patients With Pulmonary Hypertension
NCT00675051 ·Status: COMPLETED
-
Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension
NCT03554291 ·Status: COMPLETED ·Phase: PHASE2
-
Subcutaneous Treprostinil as a Bridge to Lung Transplantation in Severe Pulmonary Hypertension: A Single-Arm Retrospective Study
NCT06605326 ·Status: COMPLETED ·Phase: PHASE4